Research & Treatment News
December 31, 2009
Printer-friendly version
Castor oil packs have been used for centuries to improve liver function. Discover why many people with Hepatitis C are benefiting from this age-old folk treatment.
by Nicole Cutler, L.Ac.
Recommended by some holistic healthcare practitioners to enhance circulation, promote healing and improve liver function, castor oil packs have a long history of traditional medical use dating back to ancient Egypt. Making and applying a castor oil pack gives those with Hepatitis C a proactive way to reduce their symptoms and help their body better manage this viral infection of the liver.
Holistic Approach
A holistic approach to any illness is recognizing the innate, natural healing potential of the body. For someone with Hepatitis C, this belief means that as the entire body becomes healthier, it is better able to combat this virus and contend with its effects.
Since the liver of someone with Hepatitis C is often consumed with trying to fight and eliminate the virus, it has fewer resources to perform its regular functions - like detoxification and elimination. Thus, a holistic strategy for someone with Hepatitis C may be to support and facilitate detoxification and elimination. Accomplishing these goals contributes to the healthfulness of the entire body so that the virus can be more efficiently targeted.
Circulation Enhancement
Castor oil is derived from the castor bean (Ricinus communis) and was once taken orally as a laxative. However, castor oil is toxic and its modern day use is restricted to topical preparations on unbroken skin. When applied on the skin directly over the liver, warm castor oil packs can be beneficial to those with Hepatitis C because it is a strong circulation stimulant. This is helpful because:
· Increased circulation will reduce inflammation.
· Increased circulation will ease pain.
· Increased circulation will facilitate the detoxification process.
· Increased circulation will support toxin elimination by improving bile flow.
· Castor oil's increase in circulation boosts the production of white blood cells that help fight the Hepatitis C virus.
· Increased circulation helps with drainage of toxins to the lymph system.
How to Make a Warm Castor Oil Pack
Castor oil packs are made by soaking a piece of flannel or un-dyed wool in castor oil and placing it on the skin. The flannel is covered with a sheet of plastic, and then a hot water bottle or hot pack is placed over the plastic to heat the castor oil-soaked poultice. More specific directions are described below:
1. Place the flannel or wool in a container and soak it in castor oil so that it is saturated, but not dripping.
2. Put the saturated cloth over the liver. The liver is located in the upper right portion of the abdomen - partially above the ribs and partially beneath them.
3. Cover the saturated cloth with plastic wrap. This will reduce some of the messiness and facilitate the oil's absorption into the skin.
4. Put a hot water bottle or hot pack over the plastic wrap. Leave it in place for at least 20 minutes (up to an hour) and rest with the castor oil concoction on your abdomen.
5. Upon removing the pack, cleanse your skin with a dilute solution of water and baking soda.
6. The pack can be kept in the refrigerator in a covered container and reused many times.
7. Notorious for being thick, messy and staining, many people use separate, old sheets and clothing when bringing out their castor oil packs.
Castor oil packs can increase the body's ability to fight infection, relieve hepatic pain and inflammation while aiding in detoxification - at a fraction of the cost of similarly intended holistic health therapies. An effective technique for improving liver function, castor oil packs are a good way for those with Hepatitis C to boost their body's natural healing potential.
References:
http://altmedicine.about.com/cs/dietarytherapy/a/CastorOilPack.htm, Castor Oil Pack, Cathy
Wong, Retrieved December 5, 2009, About.com, 2009.
http://en.wikipedia.org/wiki/Edgar_Cayce, Edgar Cayce, Retrieved December 6, 2009, Wikimedia Foundation, Inc, 2009.
http://www.edgarcayce.org/health/database/health_resources/hepatitis_C.asp, Hepatitis C, Retrieved December 5, 2009, Edgar Cayce's Association for Research & Enlightenment, 2009.
http://www.ehow.com/way_5660796_natural-pain-relief-cirrhosis-liver.html, Natural Pain Relief for Cirrhosis of the Liver, LeeAnn Mullen, Retrieved December 5, 2009, eHow Inc., 2009.
http://www.liversupport.com/wordpress/2007/10/3-do-it-yourself-ways-to-help-gallbladder-and-liver-pain/, 3 Do-It-Yourself Ways to Help Gallbladder and Liver Pain, Nicole Cutler, L.Ac., Retrieved December 5, 2009, Natural Wellness, 2009.
http://www.thebody.com/content/art2055.html, The Liver and Living with HIV/AIDS: A Naturopathic Perspective, Seattle Treatment Education Project, Retrieved December 5, 2009, The Body, 2009.
Zand, Janet, et al, Smart Medicine for Healthier Living, Avery Publishing Group, Inc., Garden City Park, NY, 1999; 331.
Posted by Editors at 10:33 AM --- Printer-friendly version
December 24, 2009
Printer-friendly version
By targeting Hepatitis C's core protein, Scripps researchers have detected four promising compounds that could block viral reproduction.
Scripps Researchers Identify Novel Hepatitis C Inhibitors
Drug Discovery & Development - December 21, 2009
Scientists from the Scripps Florida campus of The Scripps Research Institute and their colleagues at Boston University have described their discovery of several novel drug-like inhibitors of the hepatitis C virus (HCV). These new inhibitors have the potential to substantially widen the current options to treat HCV infection.
Continue reading the entire article:
http://www.dddmag.com/news-Scripps-Researchers-Identify-Novel-Hepatitis-C-Inhibitors-122109.aspx
Posted by Editors at 10:12 AM --- Printer-friendly version
December 22, 2009
Printer-friendly version
For people with a chronic health concern, claims of coffee's benefits and dangers have essentially canceled each other out. However, new research on coffee and Hepatitis C tips the scale for those with this illness.
by Nicole Cutler, L.Ac.
Besides water, coffee is the world's most popular beverage. While at least half of Americans drink one cup or more per day, we are still uncertain if drinking coffee is a boon or peril to our health. Since the liver must process everything we eat or drink, those with advanced liver disease from chronic Hepatitis C are especially wary of any type of habitual consumption. However, new research demonstrates that those with chronic Hepatitis C have a lot to gain from a several cup per day coffee habit.
The Bitter Beverage
When a cup of black, relatively strong coffee is consumed, there is no doubt that bitterness dominates its flavor profile. Even though many people don't care for bitterness overwhelming their palate, the chemical compounds responsible for a bitter flavor are often beneficial to the liver. Bitter substances are known to aid a liver with chronic Hepatitis C, because they help keep the gallbladder and liver free from unnecessary obstruction by:
· Stimulating the gallbladder to release bile for fat digestion
· Stimulating detoxification activity in the liver
Thus, many liver supportive foods, medications and herbs are bitter. Chemists in Germany and the U.S. believe they have identified the chemicals that are largely responsible for coffee's bitterness. In their collaborative study, researchers found that two main classes of compounds produced during the roasting process, chlorogenic acid lactones and phenylindanes are responsible for coffee's bitterness. Both compounds are antioxidants and are not present in green, unroasted coffee beans.
New Research
Over the past several years, population studies have demonstrated that high levels of coffee consumption are associated with a decreased incidence of liver disease. However, the recipients of coffee's benefits now specifically include those with Hepatitis C.
Research released by Neal Freedman and colleagues from the National Cancer Institute examined the relationship between coffee consumption and liver disease progression in those with Hepatitis C. In 766 individuals who had Hepatitis C-related bridging fibrosis or cirrhosis (as determined by liver biopsy), and who did not respond to antiviral therapy, the following was found:
· Compared with non-coffee drinkers, people who drank more coffee had significantly healthier livers as seen by several standard liver tests.
· Study participants who drank three or more cups of coffee per day had up to a 53 percent reduction in risk for liver disease progression.
· The liver protective effect exerted by daily coffee consumption was reduced as the number of cups per day decreased.
According to Freedman, "Given the large number of people affected by HCV (Hepatitis C), it is important to identify modifiable risk factors associated with the progression of liver disease. Although we cannot rule out a possible role for other factors that go along with drinking coffee, results from our study suggest that patients with high coffee intake had a lower risk of disease progression."
Cause for Coffee Caution
Based on Freedman's research, it might seem logical for those with Hepatitis C to double their coffee intake. However, coffee does have some caveats that are worth reviewing first:
· Caffeine, coffee's main ingredient, is a mildly addictive stimulant with cardiovascular effects such as increased heart rate, increased blood pressure and occasional irregular heartbeat.
· Coffee is believed to aggravate previously existing gastritis or gastrointestinal ulcers.
· The caffeine in coffee can cause nervousness, rapid heartbeat, palpitations, sleeplessness and irritability.
· While not considered a significant risk factor for osteoporosis, high doses of coffee can impair calcium absorption, which weakens bone strength.
Besides the possible side effects listed above, the greater risk of coffee consumption lies with the ingredients typically added to it. To reduce coffee's bitterness, creating a light and sweet drink carries an entirely separate set of hazards. Because they add calories, fat and/or manmade chemicals, whipped cream, flavored syrups, half-and-half, sugar, sucralose and aspartame all contribute to health conditions that will worsen Hepatitis C.
Individuals with Hepatitis C have become accustomed to learning what they should avoid because it can damage their liver. Thus, it is a welcome change for Hepatitis C sufferers to discover that multiple, daily cups of coffee can actually prevent liver disease progression. Besides the health conditions that could be aggravated by coffee and the additives that reduce its bitterness, a majority of people with Hepatitis C have every reason to indulge in their favorite hot morning beverage.
References:
http://www.ehow.com/about_4572236_how-many-americans-drink-coffee.html, How Many Americans Drink Coffee?, Shelley Moore, Retrieved October 31, 2009, eHow, Inc., 2009.
http://www.haltctrial.org/overview.html, HALT-C Overview, Retrieved October 30, 2009, National Institutes of Health, 2009.
http://www.highlighthealth.com/food-and-nutrition/bitter-coffee-better-health/, Bitter Coffee, Better Health, Walter Jessen, Retrieved October 30, 2009, Highlihght Health, 2009.
http://www.hivandhepatitis.com/hep_c/news/2009/102309_a.html, Coffee Slows Progression of Liver Disease in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis, Retrieved October 30, 2009, hivandhepatitis.com, October 2009.
http://www.liversupport.com/wordpress/2006/06/coffees-liver-benefits/, Coffee's Liver Benefits, Nicole Cutler, L.Ac., Retrieved October 30, 2009, Natural Wellness, 2009.
http://www.prodigalgardens.info/bitter%20herbs.htm, Bitter Herbs, Retrieved October 30, 2009, Prodigal Gardens, 2009.
http://www3.interscience.wiley.com/journal/122511224/abstract?CRETRY=1&SRETRY=0, Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C, Neal D. Freeman, et al, Retrieved October 30, 2009, Hepatology, July 2009.
Posted by Editors at 11:14 AM --- Printer-friendly version
December 21, 2009
Printer-friendly version
There are several reasons why people with Hepatitis C might be discriminated against at work. However, delving deeper into these reasons clearly demonstrates that such discrimination is unacceptable.
by Nicole Cutler, L.Ac.
Mostly fueled by ignorance about Hepatitis C infection, many with this illness are subject to discrimination. Unfortunately, unfair discrimination can lead to seemingly devastating consequences to a person's employment status. Thus, those with Hepatitis C may find themselves engaged in a campaign to educate fellow workers and employers about their disease and their capacity for productivity.
Considering how many companies are currently cost-cutting, downsizing and laying off employees, job security is the source of tremendous stress for a majority of Americans. For the four to five million Americans with the disease, discrimination based on Hepatitis C can be especially worrisome in the workplace. Understanding why Hepatitis C could be discriminated against can help those with this disease decide with whom - and how - they discuss their health status.
The Basis of Discrimination
Two primary reasons for discrimination are fear and ignorance. Based on these qualifiers, Hepatitis C is a prime candidate for discrimination because of:
1. Transmission - Because there is no Hepatitis C vaccine and no guaranteed cure, people are afraid of getting it. Many do not know that Hepatitis C is only transmitted via blood- to-blood contact. Such ignorance about its transmission can make some fearful about casual contact (as happens in most work environments) with a person who has Hepatitis C.
2. Fear of Illness - Some individuals are uncomfortable being around others who are sick. Being uncomfortable around others with an illness is how certain people protect themselves from their personal fear of disease. A self-serving, coping mechanism, this discomfort may cause social rejection of people with disease to spare risking emotional exposure to suffering and/or death.
Justification for Discrimination
For the most part, receiving different treatment for Hepatitis C status is not just unfair, but it is against the law. However, some employers may feel justified in their discriminatory stance against employees with this illness. Business owners concerned about employee attendance and productivity may assume that someone with Hepatitis C would perform poorly in these areas. This is due to an assumption that those with Hepatitis C are subject to repeated doctor's appointments or feeling fatigued or sick often.
According to "The Hepatitis C Survey: Bridging the Gaps in HCV Understanding and Treatment" - conducted by TNS and Synovate and sponsored by Novartis and Human Genome Sciences - one area in which this disease exerts a toll on patients is in employment. In this survey, Hepatitis C patients described missing days at work, decreases in productivity and lost income. The following statistics were deciphered:
1. 44 percent of respondents reported taking time off from work
2. 36 percent of respondents reported reduced productivity
These statistics could be of concern to employers who are forced to maximize their employees' efficiency. However, these statistics must be put into context. Without a reliable comparison of how many people without Hepatitis C take time off from work and how many without Hepatitis C experience reduced work productivity, chances are it would not be that far from those surveyed. This is because, at some time or another, everybody must contend with illness and not feeling up to par.
From another perspective, today's employment hardships intensify the competition for workers to keep their jobs. While such competition can prevent people from taking time off from work, it certainly diminishes their productivity. According to an article published in the October 2009 edition of the Harvard Business Review, making workaholics take time off improved their work performance.
Unless a person with Hepatitis C is exhibiting a behavior or pattern that would be problematic for other employees, their job security should not be threatened. To do so is discrimination, an unlawful incarnation of fear and ignorance. As more people learn to cope with their own fears around illness, that casual contact does not transmit Hepatitis C and that a person with Hepatitis C is no more apt to miss work or have diminished productivity compared to others, discriminating against this disease in the workplace will no longer be tolerated.
References:
http://apps.leg.wa.gov/Rcw/default.aspx?cite=49.60.172, Unfair practices with respect to HIV or hepatitis C infection, Retrieved November 4, 2009, Washington State Legislature, 2009.
http://drugstorenews.com/%28S%281ednfv453jha1c45rnnwft45%29%29/story.aspx?id=120727&menuid=335, Survey finds hepatitis C patients adversely affected by medications, Alaric DeArment, Retrieved November 4, 2009, Drug Store News, October 2009.
http://hbr.harvardbusiness.org/2009/10/making-time-off-predictable-and-required/ar/1, Making Time Off Predictable--and Required, Leslie A. Perlow, Jessica L. Porter, Retrieved November 5, 2009, Harvard Business Review, Harvard Business Publishing, October 2009.
http://www.hepatitis-central.com/mt/archives/2007/08/breaking_the_he.html, Breaking the Hepatitis C Social Stigma, Nicole Cutler, L.Ac., Retrieved November 5, 2009, Natural Wellness, 2009.
http://www.hepeducation.org/supportgroups/documents/DISCLOSURE.pdf, Hepatitis C Disclosure, Alan Franciscus, Retrieved November, 4, 2009, Hepatitis C Support Project, 2009.
http://www.nolo.com/legal-encyclopedia/question-28290.html, I was fired because of my hepatitis C: Was this legal?, Retrieved November 4, 2009, Nolo, 2009.
Posted by Editors at 2:05 PM --- Printer-friendly version
December 11, 2009
Printer-friendly version
By thinking outside the box, the Denmark-based company Santaris Pharma A/S has developed a drug targeting a specific molecule necessary for Hepatitis C replication. Although a very small trial, SPC3649 demonstrates a significant Hepatitis C viral load decline in primates.
New Hepatitis C Treatment Shows Promise
Drug prevented virus from replicating in the livers of primates
By Jennifer Thomas
HealthDay Reporter
THURSDAY, Dec. 3 (HealthDay News) -- A new drug to treat hepatitis C has shown promise in a primate study.
The drug, called SPC3649, uses a new strategy to prevent the hepatitis C virus from replicating. Unlike other antivirals that target the virus itself, the new DNA-based drug targets a small RNA molecule in the liver that hepatitis C needs to replicate, the researchers explained.
By inhibiting the molecule, SPC3649 reduced hepatitis C virus levels in the liver and in the bloodstream in chimpanzees that received the highest dose by 350-fold.
Continue reading the entire article:
http://health.usnews.com/articles/health/healthday/2009/12/03/new-hepatitis-c-treatment-shows-promise.html
Posted by Editors at 5:08 PM --- Printer-friendly version
December 8, 2009
Printer-friendly version
Even though an estimated 170 million people worldwide are infected with Hepatitis C, the current treatment can only help about half of them. However, new research suggests that a common vitamin could greatly increase Hepatitis C treatment's effectiveness.
by Nicole Cutler, L.Ac.
Previous research has provided evidence pointing toward a Vitamin D deficiency in those with chronic Hepatitis C. This association has spawned an interest in how Vitamin D could help those with viral hepatitis. While Vitamin D supplementation may help prevent some complications of advancing liver disease, deciphering this vitamin's role in Hepatitis C has been relatively limited - until now.
Approximately 15 percent of those infected with Hepatitis C have an immune system that is able to eliminate the virus. Unfortunately, the remaining 85 percent infected with Hepatitis C end up with a chronic illness. If the Hepatitis C virus (HCV) is not eradicated, it can progress to more serious forms of liver disease like cirrhosis, liver cancer or liver failure.
Combination Therapy
While great strides in HCV treatment have been made over the past decade, the current standard of care can help approximately 50 percent of those infected beat the virus. Referred to as combination therapy, this standard treatment consists of two drugs: pegylated interferon and ribavirin.
About half of those with the virus do not respond to combination therapy. Consequently, the pharmaceutical industry has been dedicating enormous resources into improving these odds. Taking their cue from the successful management of HIV/AIDS, much research is focused on developing a third drug, that when added to pegylated interferon and ribavirin, will create a highly effective triple therapy for Hepatitis C.
Vitamin D for Triple Therapy
Based on results of a preliminary Israeli study, Vitamin D could represent the best possible candidate for a third substance to comprise triple Hepatitis C therapy. As reported at the 2009 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), adding a daily dose of Vitamin D to the regimen of pegylated interferon-alfa 2 and ribavirin might increase Hepatitis C response rates to therapy.
According to lead investigator Saif M. Abu-Mouch, M.D., from the Department of Hepatology, Hillel Yaffe Medical Center in Hadera, Israel, "This preliminary study confirms the benefit of adding Vitamin D to conventional antiviral therapy in patients with chronic Hepatitis C." Details of Abu-Mouch's study are described below:
· 89 participants with HCV were recruited.
· 58 patients received peginterferon-alfa 2b 1.5 ug/kg once per week and ribavirin 1000 to 2000 mg daily (control group).
· 31 patients received the same treatment plus Vitamin D 1000 to 4000 IU daily.
· By the fourth week of treatment, a rapid virological response was seen in 44 percent of the patients who received Vitamin D and in 18 percent of the control group.
· At the twelfth week of treatment, 96 percent of the group who received the addition of Vitamin D and 48 percent of the control group tested negative for HCV.
If the results of this study were to be extrapolated and applied to the general Hepatitis C population, adding Vitamin D could nearly double the current success rate of HCV antiviral therapy. When added to pegylated interferon and ribavirin, even rigorously tested drugs in development haven't been able to claim a 96 percent success rate. Thus, we can expect to see a great deal of excitement and larger human trials exploring the potential of Vitamin D as the missing ingredient in Hepatitis C triple drug therapy.
Editor's Note: For more information about Hepatitis C and Vitamin D deficiency, including potential dangers of a Vitamin D overdose, read Caution: Hepatitis C and Vitamin D Deficiency.
References:
http://www.associatedcontent.com/article/2364654/can_vitamin_d_treat_chronic_hepatitis.html?cat=70, Can Vitamin D Treat Chronic Hepatitis C Infection?, Kristie Leong, MD, Retrieved November 28, 2009, Associated Content, Inc., November 2009.
http://www.hcvadvocate.org/news/newsRev/2009/NewsRev-337.html#_Vitamin_D_Boosts, Vitamin D Boosts Treatment of Chronic Hepatitis C, Maryann Gromisch, RN, Retrieved November 28, 2009, hcvadvocate.org, November 2009.
http://www.hepatitis-central.com/mt/archives/2008/10/hepatitis_c_and_11.html, Caution: Hepatitis C and Vitamin D Deficiency, Nicole Cutler, L.Ac., Retrieved November 28, 2009, Natural Wellness, 2009.
http://www.medscape.com/viewarticle/711902, Vitamin D Has Benefits in Chronic HCV Infection, Megan Brooks, Retrieved November 28, 2009, Medscape LLC, 2009.
Posted by Editors at 9:57 AM --- Printer-friendly version
December 4, 2009
Printer-friendly version
Discover four tips that can help those with Hepatitis C avoid additional liver damage from the high percentage of toxins found in wintertime indoor air.
by Nicole Cutler, L.Ac.
According to the Environmental Protection Agency, a growing body of scientific evidence indicates that indoor air is more seriously polluted than outdoor air - even in the largest and most industrialized cities. Because pollution is toxic to the liver, those with Hepatitis C are especially vulnerable to polluted indoor air. Furthermore, the time typically spent indoors during the winter increases someone with Hepatitis C's vulnerability to indoor air toxins during the colder months.
Depending on the health issues of each individual, exposure to environmental pollutants poses varying degrees of risk. Unfortunately, those with Hepatitis C are more susceptible to liver damage from environmental toxins because:
· Their liver isn't working as efficiently, so toxins normally processed by the liver remain in the body longer than usual. With toxins lingering in the body longer, those with Hepatitis C are more likely to incur cellular damage from the toxins.
· When toxins cause injury to liver tissue, healthy livers typically rejuvenate quickly. However, those who already have liver damage from Hepatitis C are likely to have a much harder time recovering from toxin-causing injury.
The primary causes of indoor air quality problems in homes are from sources that release gases or particles into the air. Another prime culprit of indoor air pollution is inadequate ventilation - by not bringing in enough outdoor air to dilute emissions from indoor sources and by not carrying indoor air pollutants out of the home.
Homes contain many sources of indoor air pollution, including:
· Combustion sources like oil, gas, kerosene, coal and wood
· Tobacco smoke - and its toxic aftermath
· Building materials and furnishings like asbestos-containing insulation and cabinetry or furniture made of certain pressed wood products
· Household cleaning and maintenance products
· Central heating and humidification devices
As a result of dropping temperatures outside, many of us spend greater amounts of time indoors. Due to the fact that windows and doors are usually sealed tight during the winter to conserve energy, the concentration of indoor air pollution always increases during this time. Since those with Hepatitis C are more susceptible to indoor air pollution, the following four tips can help minimize the toxins breathed in each day:
Tip 1. Plants - NASA researchers found that common houseplants effectively purified the air in spacecraft. Household plants can remove common chemicals from the air, such as formaldehyde, benzene and carbon monoxide. Peace lily, bamboo, palm, English ivy, mums, golden pothos, nepthylis, spider plant, snake plant, aloe, philodendron and gerbera daisies are among the top air-purifying plants.
Tip 2. Low VOC Paint - Volatile organic compounds (VOCs) are plentiful in paint and are a known lung, liver, kidney and central nervous system toxin. If repainting a room is on your to do list this winter, choose one with low VOCs.
Tip 3. Replace Heating System Air Filter - Replacing a standard air filter with one that is pleated and electrostatic will capture more pollutants from a furnace's forced air. Experts suggest using a minimum efficiency reporting value (MERV) rating of 10 or higher.
Tip 4. Choose Cleaners Wisely - Cleaning products are known to harbor some of the most hazardous chemicals known. While several environment-friendly companies now offer toxin-free cleaning products, there are also many ways to make your own safe and effective cleaners.
Because many are cooped up inside, winter is definitely a time for those with Hepatitis C to be aware of indoor air pollution. The increased demand that indoor air pollution puts on the liver is best averted by reducing the amount of airborne pollutants in your space. Simple steps like adorning your living area with several houseplants, using low VOC paint, putting a new, pleated, electrostatic air filter in your heating system and using toxin-free cleaners all add up to improved indoor air quality. By reducing indoor air pollution, those with Hepatitis C can emerge in the spring unscathed by wintertime indoor air.
References:
http://www.care2.com/greenliving/simple-steps-to-clean-your-indoor-air.html, Simple Steps to Clean Your Indoor Air, Retrieved October 17, 2009, care2.com, 2009.
http://www.epa.gov/iaq/pubs/insidest.html, The Inside Story: A Guide to Indoor Air Quality, Retrieved October 17, 2009, United States Environmental Protection Agency, 2009.
http://www.hepatitis-central.com/mt/archives/2009/04/cleaning_safety.html, Cleaning Safety for Hepatitis C, Nicole Cutler, L.Ac., MTCM, Natural Wellness, 2009.
Paul, Nina L, Gina Pollichino, Living with Hepatitis C for Dummies, Wiley Publishing Inc., Hoboken, NJ, 2005; 158.
Posted by Editors at 11:02 AM --- Printer-friendly version
December 3, 2009
Printer-friendly version
A small study of Inovio Biomedical's Hepatitis C vaccine employing electric pulse technology yields encouraging safety data.
Inovio Biomedical's hepatitis C vaccine progresses
Philadelphia Business Journal - by John George Staff Writer
Monday, November 30, 2009
Inovio Biomedical Corp. said Monday its drug-development partner Tripep completed a phase-I clinical study of its hepatitis C DNA vaccine.
Tripep of Sweden tested its vaccine, called ChronVac-C and delivered using Inovio's electroporation technology, in 12 patients with positive results.
Continue reading the entire article:
http://philadelphia.bizjournals.com/philadelphia/stories/2009/11/30/daily1.html
Posted by Editors at 11:00 AM --- Printer-friendly version
